Glomerulonephritis membranous – Diagnostics – Overview of Information and Clinical Research

Membranous nephropathy, also called membranous glomerulonephritis, is a rare kidney disease where the body’s immune system attacks the tiny filtering units in the kidneys. Diagnosing this condition requires careful evaluation, starting with recognizing symptoms like swelling and foamy urine, followed by blood and urine tests, and often confirmed through a kidney biopsy. Early and accurate diagnosis is essential to protect kidney function and prevent serious complications.

Introduction: Who Should Seek Diagnostic Testing

People who notice unusual changes in their body should consider seeking medical evaluation for membranous nephropathy. If you experience swelling in your hands, feet, or face that doesn’t go away, this could be a warning sign. Your urine might look foamy or bubbly, similar to soap suds, which happens when too much protein leaks into it. Some people also notice they’re gaining weight unexpectedly, not because they’re eating more, but because their body is holding onto water it should be getting rid of.^[1]

It’s important to understand that many people with membranous nephropathy don’t feel sick at first. The disease can quietly damage your kidneys for months or even years before you notice anything wrong. This is why regular health checkups matter, especially if you have conditions like lupus (an illness where your immune system attacks your own body), hepatitis B or C (liver infections), or if you take certain medications regularly. Doctors sometimes discover membranous nephropathy during routine urine tests ordered for other reasons, which is actually a lucky break because catching it early gives you more treatment options.^[2]

⚠️ Important

Some people have membranous nephropathy for several years without knowing it. If you notice persistent swelling, changes in urination patterns, extreme tiredness, or trouble breathing, don’t wait to see a doctor. These symptoms might seem minor at first, but they could signal that your kidneys need immediate attention.

Men over the age of 50 are more likely to develop this condition than women or younger people, though anyone can get it. If you have rheumatoid arthritis (painful joint inflammation), cancer (particularly of the colon or lung), or have been exposed to heavy metals like mercury, your doctor might want to test you even if you feel fine. Children rarely develop membranous nephropathy, but when they do, quick diagnosis becomes even more important because their growing bodies are more vulnerable to kidney damage.^[1]^[5]

You should also seek testing if you’ve recently been treated for certain infections or started new medications. Some drugs, particularly nonsteroidal anti-inflammatory drugs (commonly called NSAIDs, like ibuprofen), a medication called penicillamine, and even some treatments for arthritis can trigger membranous nephropathy as a side effect. Your healthcare provider needs to know about every medicine and supplement you take, including over-the-counter products, because this information helps them understand what might be causing your kidney problems.^[2]

Classic Diagnostic Methods

When you visit a doctor with concerns about kidney problems, they start with a physical examination. The doctor will check your blood pressure because high blood pressure often accompanies kidney disease. They’ll look for swelling in your ankles, feet, and face, and they might press gently on these areas to see if the fluid moves. They’ll also measure your weight and height because sudden weight gain can indicate your body is retaining water instead of passing it out through urine. These simple checks give the doctor important clues about what’s happening inside your body.^[5]

The next step usually involves testing your urine. A urinalysis is a basic test where you provide a urine sample that gets examined in a laboratory. Technicians look for protein in your urine, which normally shouldn’t be there in large amounts. If your kidneys are healthy, they keep protein in your blood where it belongs. But when membranous nephropathy damages the kidney filters, protein leaks through into your urine. The test also checks for blood in your urine, though this is less common with membranous nephropathy compared to other kidney diseases. Sometimes you’ll hear doctors talk about proteinuria, which simply means protein in the urine, or hematuria, which means blood in the urine.^[5]^[1]

Doctors also order blood tests to understand how well your kidneys are working. One key test measures serum creatinine, which is a waste product your kidneys normally filter out. If creatinine levels in your blood are high, it means your kidneys aren’t cleaning your blood properly. Another important measure is serum albumin, a type of protein that should stay in your blood. Low albumin levels suggest protein is escaping through damaged kidneys. Blood tests also check your cholesterol levels because people with membranous nephropathy often have high cholesterol, which increases the risk of heart problems.^[5]

A more specific blood test looks for certain antibodies (proteins made by your immune system). About 70 to 80 percent of people with primary membranous nephropathy have antibodies against something called the phospholipase A2 receptor, or PLA2R for short. This test is revolutionary because finding these antibodies in your blood strongly suggests you have membranous nephropathy, even before a kidney biopsy. Another antibody test looks for anti-THSD7A antibodies, which appear in about 2 to 5 percent of cases. These blood tests are especially helpful because they’re less invasive than a biopsy, though they can’t completely replace it in all situations.^[4]^[3]

Before confirming membranous nephropathy, doctors need to rule out other conditions that might be causing your symptoms. They might test for antinuclear antibodies (ANA) to check for lupus, or order tests for hepatitis B and C, syphilis, and malaria if you’ve been exposed to these infections. They might also test complement levels (proteins involved in immune system function) and look for cryoglobulins (abnormal proteins that can appear in certain diseases). These additional tests help determine whether your membranous nephropathy is primary (happening on its own) or secondary (caused by another disease or medication).^[5]

A kidney ultrasound uses sound waves to create pictures of your kidneys. This painless test shows the size and shape of your kidneys and can detect abnormalities. It doesn’t definitively diagnose membranous nephropathy, but it helps doctors see if there are other problems like kidney stones or blocked urine flow. Sometimes doctors combine ultrasound with Doppler studies to examine blood flow through the kidney arteries, making sure blood is reaching your kidneys properly.^[5]

The most definitive diagnostic method is a kidney biopsy. During this procedure, a doctor removes a tiny piece of your kidney tissue using a special needle. You might receive local anesthesia (numbing medicine) and sometimes light sedation to help you relax. The doctor uses ultrasound or another imaging technique to guide the needle to the right spot in your kidney. The entire procedure usually takes less than an hour. After the tissue is removed, specialists examine it under a microscope to see the exact changes in your kidney’s structure. In membranous nephropathy, they look for thickening of the glomerular basement membrane (the tiny filter walls) and specific patterns of immune deposits.^[5]^[1]

However, doctors don’t always need a biopsy right away. If you have clear symptoms of nephrotic syndrome (a group of symptoms including protein in urine, swelling, and low blood protein), positive anti-PLA2R antibodies in your blood, and your kidney function is still good, some doctors might start treatment without a biopsy. This approach avoids the small risks that come with any invasive procedure. But if your case is unclear, if blood tests are negative, or if you’re not responding to treatment, a biopsy becomes necessary to confirm the diagnosis and guide treatment decisions.^[3]

⚠️ Important

A kidney biopsy is generally safe, but like any medical procedure, it carries small risks including bleeding, infection, or injury to nearby organs. Your doctor will explain these risks and answer your questions before the procedure. Most people go home the same day and can return to normal activities within a few days, though you should avoid heavy lifting and strenuous exercise for about two weeks.

Diagnostics for Clinical Trial Qualification

When researchers test new treatments for membranous nephropathy in clinical trials, they use strict diagnostic criteria to make sure all participants truly have the disease. These standards are more detailed than what doctors use in everyday practice because research requires precise measurements to determine if a treatment actually works. If you’re considering joining a clinical trial, understanding these requirements helps you know what to expect.^[8]

Most clinical trials require a confirmed kidney biopsy showing membranous nephropathy before you can enroll. The biopsy results must show the characteristic changes in kidney tissue that define this disease. Some trials specifically look for people with primary membranous nephropathy and exclude those whose disease is secondary to other conditions like lupus or hepatitis. This means you might need additional blood tests to prove you don’t have these underlying diseases. The exclusion of secondary causes ensures that researchers are studying one specific form of the disease, which makes their results more reliable.^[4]

Clinical trials often require measurements of how much protein you’re losing in your urine. You might need to collect all your urine over 24 hours (yes, every single time you go to the bathroom) so the laboratory can measure the total protein amount. Many trials only accept patients losing more than 3.5 grams of protein per day, which defines nephrotic range proteinuria. Some trials accept patients with lower amounts if they have other concerning features. An alternative to 24-hour collection is the urine protein to creatinine ratio, which uses a single urine sample but still provides accurate information about your protein loss.^[2]

Blood tests measuring kidney function are essential for trial qualification. Trials use estimated glomerular filtration rate (eGFR) to determine how well your kidneys are filtering waste. This number is calculated from your blood creatinine level, age, sex, and sometimes race. Different trials accept different eGFR ranges depending on which treatment they’re testing. Some trials only enroll people with well-functioning kidneys (eGFR above 60), while others specifically study people whose kidneys are already more damaged. Serum albumin levels also matter because they indicate how severe your protein loss has become.^[5]

Anti-PLA2R antibody testing has become increasingly important for clinical trial enrollment. Some newer trials specifically recruit patients who test positive for these antibodies, while other trials might focus on antibody-negative patients. Researchers track antibody levels throughout the study because changes in antibody amounts can predict whether treatment is working, often before other signs of improvement appear. If antibody levels go down, it usually means the treatment is helping; if they stay high or increase, the treatment might not be effective for you.^[4]^[9]

Trials often require baseline measurements of your blood pressure, cholesterol levels, and tests to check for blood clots. Membranous nephropathy increases the risk of dangerous clots in your legs (called deep vein thrombosis) or lungs (called pulmonary embolism), especially when your albumin is very low. Some trials might require an ultrasound of your leg veins or other imaging to make sure you don’t already have hidden clots before starting an experimental treatment.^[1]

Many clinical trials exclude people who have recently received certain treatments. If you’ve taken immunosuppressive medications (drugs that calm down your immune system) like cyclophosphamide, rituximab, or high-dose steroids within the past few months, you might need to wait before enrolling. This waiting period, often called a washout period, ensures that any effects from previous treatments don’t interfere with measuring how well the experimental treatment works. Each trial has different rules about which medications you must stop and how long you must wait.^[8]

Some trials focus on patients at high risk of kidney function decline. They might calculate your risk level using several factors: how much protein you’re losing, your kidney function numbers, your blood pressure, and how long you’ve had the disease. They might use risk prediction tools to categorize you as low, moderate, high, or very high risk. High-risk patients are more likely to benefit from aggressive treatments being tested in trials, while low-risk patients might not need such strong interventions.^[12]

Throughout a clinical trial, you’ll undergo repeated testing to track your progress. This might include monthly blood and urine tests, regular blood pressure checks, and periodic kidney biopsies to see how the tissue is responding to treatment. Some trials measure antibody levels every few weeks. While this frequent testing might feel burdensome, it’s necessary for researchers to understand exactly how the experimental treatment affects different aspects of your disease over time.^[9]

Prognosis and Survival Rate

Prognosis

The outlook for people with membranous nephropathy varies widely depending on several factors. About one-third of patients experience what doctors call spontaneous remission, meaning their kidneys start functioning better on their own without strong medications. These patients see their protein loss decrease, their swelling goes away, and their blood protein levels return to normal. This fortunate outcome is more common in people who have only mild protein loss when first diagnosed.^[8]

Another third of patients continue to lose protein in their urine but maintain stable kidney function for many years. Their kidneys keep working well enough to filter waste, even though they’re not completely normal. These patients need ongoing monitoring and treatment to control symptoms like high blood pressure and high cholesterol, but they don’t progress to kidney failure. They can live relatively normal lives with proper medical care and lifestyle adjustments.^[8]

Unfortunately, the remaining third of patients experience progressive kidney disease that eventually leads to end-stage kidney failure. These patients eventually need dialysis (a machine that filters their blood) or a kidney transplant to survive. Several warning signs suggest worse outcomes: being male, older than 50, having very high protein loss (more than 8-10 grams per day), having elevated creatinine when first diagnosed, and having significant scarring visible on kidney biopsy. High blood pressure and high cholesterol that are difficult to control also predict worse outcomes.^[2]

The level of anti-PLA2R antibodies in your blood can help predict your prognosis. People with very high antibody levels at diagnosis are more likely to have persistent disease and need treatment. If antibody levels stay high despite treatment, the chance of kidney function worsening increases. On the other hand, when antibody levels decrease or disappear completely, kidney function often improves, even if this takes months or years to happen. Monitoring these antibody levels helps doctors adjust your treatment plan before kidney damage becomes permanent.^[3]^[9]

Patients with secondary membranous nephropathy (caused by other diseases or medications) often have better outcomes if doctors can treat the underlying cause. For example, successfully treating hepatitis B infection can lead to complete recovery of kidney function. Stopping a medication that triggered the disease can allow kidneys to heal. People whose membranous nephropathy develops from cancer might see improvement after cancer treatment, though this depends on the cancer type and whether it can be cured.^[8]

Complications from membranous nephropathy significantly affect long-term outcomes. Blood clots are a serious concern, particularly when albumin levels drop very low (below 2.0-2.5 grams per deciliter). These clots can be life-threatening if they travel to the lungs. Heart disease and strokes are also more common because of high cholesterol and long-term inflammation. Infections occur more frequently, especially in patients taking immunosuppressive medications. Managing these complications requires careful attention to medications, diet, and lifestyle choices.^[1]

Children who develop membranous nephropathy generally have better outcomes than adults. They’re more likely to experience spontaneous remission and less likely to progress to kidney failure. However, when children do develop severe disease, it requires aggressive treatment to protect their developing kidneys. Long-term follow-up is essential because kidney problems that start in childhood can have consequences decades later.^[2]

Survival rate

Specific survival rate statistics for membranous nephropathy are not clearly provided in the available sources. However, the sources indicate that membranous nephropathy can follow three general paths: about one-third of patients achieve remission, one-third maintain stable kidney function with persistent protein loss, and one-third progress to kidney failure. The time frame for these outcomes varies considerably between individuals, ranging from months to many years.^[8]

The risk of progressing to end-stage kidney disease requiring dialysis or transplant depends heavily on individual factors. Patients with severe symptoms at diagnosis, very high protein loss, declining kidney function, and uncontrolled antibody levels face higher risks of kidney failure within 5 to 10 years. Those with milder disease and favorable factors might maintain good kidney function for decades or even for their entire lives.^[2]

Patients who do progress to kidney failure have several treatment options that significantly improve survival. Dialysis can effectively replace kidney function, though it requires regular treatments several times per week. Kidney transplantation offers better quality of life and longer survival than long-term dialysis. After successful kidney transplant, many patients live 10, 20, or more years, though there is a risk that membranous nephropathy can recur in the transplanted kidney. Newer immunosuppressive medications have improved outcomes for transplant patients considerably.^[8]

It’s important to remember that statistics represent large groups of patients and cannot predict any individual’s outcome. Each person’s disease behaves differently, and many factors influence prognosis including how early the disease is caught, how well you respond to treatment, and how carefully you manage complications. Regular follow-up with a kidney specialist and adherence to treatment recommendations significantly improve long-term outcomes regardless of initial disease severity.^[12]

#1 Clinical Trials Search in Europe